Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 11,160
-100 (-0.89%)
Jul 18, 2025, 3:30 PM KST
Tdspharm Revenue
Tdspharm had revenue of 5.28B KRW in the quarter ending March 31, 2025, a decrease of -40.74%. This brings the company's revenue in the last twelve months to 25.43B, down -15.36% year-over-year. In the year 2024, Tdspharm had annual revenue of 27.52B, down -8.42%.
Revenue (ttm)
25.43B
Revenue Growth
-15.36%
P/S Ratio
2.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.71B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| Peptron | 4.30B |
| PharmaResearch | 392.31B |